Targeting the RNA m6A Reader YTHDF2 Selectively Compromises Cancer Stem Cells in Acute Myeloid Leukemia
J Paris(Queen Mary University of London), Kamil R. Kranc(Queen Mary University of London), Ivayla Ivanova(Edinburgh Genomics), Catarina Sepúlveda(MRC Centre for Regenerative Medicine), David Wotherspoon(Queen Mary University of London), Frédéric Mazurier(Centre National de la Recherche Scientifique), Milica Vukovic(MRC Centre for Regenerative Medicine), Andrea Tavosanis(Springer Nature (Germany)), Douglas Vernimmen(Roslin Institute), Annika Sarapuu(Queen Mary University of London), Marcos Morgan(MRC Centre for Regenerative Medicine), Ali Nehme(Université de Tours), Joana Campos(Queen Mary University of London), Hannah Lawson(University of London), Richard I. Gregory(Boston Children's Hospital), Dónal O’Carroll(MRC Centre for Regenerative Medicine), Christian Much(MRC Centre for Regenerative Medicine), Amélie V. Guitart(MRC Centre for Regenerative Medicine), Gary J. Spencer(University of Manchester), Alena Shmakova(University of Dundee), Lewis Allen(MRC Centre for Regenerative Medicine), Tim C. P. Somervaille(University of Manchester), Louie N. van de Lagemaat(Queen Mary University of London), Junho Choe(Harvard University), Christopher Mapperley(MRC Centre for Regenerative Medicine), Ali Azar(Queen Mary University of London), Arnaud Villacreces(MRC Centre for Regenerative Medicine)
Cited by 552
Related Papers
The RNA m 6 A Reader YTHDF2 Is Essential for the Post-transcriptional Regulation of the Maternal Transcriptome and Oocyte Competence
|Molecular Cell|2017|404
METTL1-mediated m7G modification of Arg-TCT tRNA drives oncogenic transformation
|Molecular Cell|2021|359
Trim71 cooperates with microRNAs to repress Cdkn1a expression and promote embryonic stem cell proliferation
|Nature Communications|2012|151
Exon junction complex shapes the m6A epitranscriptome
|Nature Communications|2022|148
The mRNA m6A reader YTHDF2 suppresses proinflammatory pathways and sustains hematopoietic stem cell function
|The Journal of Experimental Medicine|2020|145